share_log

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 45.5% in January

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF) Short Interest Up 45.5% in January

零時生命科學有限公司 1 月短息增 45.5%
Financial News Live ·  2023/02/14 13:01

StageZero Life Sciences Ltd. (OTCMKTS:SZLSF – Get Rating) saw a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 6,400 shares, an increase of 45.5% from the January 15th total of 4,400 shares. Based on an average daily trading volume, of 4,400 shares, the days-to-cover ratio is currently 1.5 days.

零生命科學有限公司(OTCMKTS:SZLSF-獲取評級)在一月份短期興趣顯著增加。截至 1 月 31 日,總共有 6,400 股短期利息,較 1 月 15 日的 4,400 股股份增加了 45.5%。根據 4,400 股的平均每日交易量計算,日數保障比率目前為 1.5 天。

StageZero Life Sciences Stock Performance

零階段生命科學股票表現

SZLSF stock traded up $0.00 during midday trading on Monday, hitting $0.05. 1,000 shares of the stock traded hands, compared to its average volume of 6,350. The firm has a market cap of $5.60 million, a P/E ratio of -0.76 and a beta of 0.90. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.08 and a quick ratio of 0.04. The stock's fifty day simple moving average is $0.05 and its 200-day simple moving average is $0.06. StageZero Life Sciences has a 1-year low of $0.04 and a 1-year high of $0.20.

星期一中午交易時間上漲 0.00 美元,與其平均成交量 6,350 宗相比,上漲 0.05 美元。該公司的市值為 560 萬美元,市盈率為 -0.76,貝塔值為 0.90。該公司的債務與權益比率為 0.44,流動比率為 0.08,快速比率為 0.04。該股的五十天簡單移動平均線為 0.05 美元,其 200 天的簡單移動平均線為 0.06 美元。零階段生命科學的 1 年低點為 0.04 美元,1 年新高為 0.20 美元。

Get
取得
StageZero Life Sciences
零階段生命科學
alerts:
警報:

StageZero Life Sciences Company Profile

零階段生命科學公司簡介

(Get Rating)

(取得評分)

StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K.
StageZero 生命科學有限公司致力於開發和商業化專有的分子診斷測試,用於檢測疾病和個人化健康管理,專注於與癌症相關的適應症。其產品包括哨兵原理和上校安。該公司由劉忠欽和 K 創立。

Featured Stories

特色故事

  • Get a free copy of the StockNews.com research report on StageZero Life Sciences (SZLSF)
  • Should Medtronic's Recent Colibri Patent Controversy Concern You?
  • Checkpoint Software Helps Cyber Security Stocks Bottom
  • Under Armour Stock, Gap and Crap, Here's Why
  • Is Chevron Positioned To Take Energy Sector Leadership?
  • What Does the Consumer Price Index Measure?
  • 免費獲取有關階段零生命科學研究報告的副本
  • 美敦力最近的 Colibri 專利爭議應該關注您嗎?
  • 檢查點軟件幫助網絡安全股票底部
  • 在裝甲庫存,差距和廢話,這就是為什麼
  • 雪佛龍定位採取能源部門的領導地位嗎?
  • 消費者價格指數衡量什麼?

Receive News & Ratings for StageZero Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for StageZero Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

接收 StageZero 生命科學日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件通訊接收 StageZero 生命科學及相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論